Literature DB >> 18442323

A highly sensitive diagnostic assay for aggregate-related diseases, including prion diseases and Alzheimer's disease.

Eva Birkmann1, Franziska Henke, Susanne Aileen Funke, Oliver Bannach, Detlev Riesner, Dieter Willbold.   

Abstract

Prion diseases, Alzheimer's disease, and Parkinson's disease are age-related neurodegenerative diseases that are characterized by the formation of protein aggregates during the progress of the disease. Although it is still not known whether these aggregates are causative for, or symptoms of, the disease. Many studies show that aggregates or even oligomers of the according proteins are neurotoxic and thus may lead to neurodegeneration. To understand disease-associated or causative mechanisms in respect to protein aggregation, an ultrasensitive tool to quantify these disease-related aggregates is required. In this study we introduce a specificity-enhanced version of surface-FIDA as an approach to count even single aggregates in tissue homogenate and body liquids.

Entities:  

Mesh:

Year:  2008        PMID: 18442323     DOI: 10.1089/rej.2008.0697

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  2 in total

1.  Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.

Authors:  Christina D Orrú; Jason M Wilham; Lynne D Raymond; Franziska Kuhn; Björn Schroeder; Alex J Raeber; Byron Caughey
Journal:  MBio       Date:  2011-05-10       Impact factor: 7.867

2.  Mechanism of scrapie prion precipitation with phosphotungstate anions.

Authors:  Dana J Levine; Jan Stöhr; Lillian E Falese; Julian Ollesch; Holger Wille; Stanley B Prusiner; Jeffrey R Long
Journal:  ACS Chem Biol       Date:  2015-02-19       Impact factor: 5.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.